Infectious Diseases (all articles)
Universal COVID-19 testing may reduce spread in long-term care facilities
22 Jul, 2020 | 02:18h | UTCCommentaries: Universal COVID-19 testing in nursing homes may limit transmission – UPI AND Report Underscores Importance Of Universal Covid-19 Testing In Nursing Homes – MedicalResearch.com
Assessing the impact of coordinated COVID-19 exit strategies across Europe
22 Jul, 2020 | 02:20h | UTCAssessing the impact of coordinated COVID-19 exit strategies across Europe – Science
Commentary: Coordinated exit strategies crucial to avoid virus second-wave in Europe – University of Southampton
Phase 2 randomized trial: immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults
21 Jul, 2020 | 09:29h | UTCCommentaries: China’s Ad5 vectored COVID-19 vaccine safe and induces immune response – News Medical AND CanSino COVID-19 vaccine generates immune response in 90% of patients – UPI
Related Commentary on Twitter
https://twitter.com/TheLancet/status/1285209554775617536
Editorial: encouraging results from phase 1/2 COVID-19 vaccine trials
21 Jul, 2020 | 09:35h | UTCEncouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet
Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre
[Press release-based medicine…] Synairgen announces positive results from trial of SNG001 in hospitalized COVID-19 patients
21 Jul, 2020 | 09:27h | UTCSynairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
Commentaries: New Treatment for Covid-19 Shows Promise, but Scientists Urge Caution – The New York Times AND Expert reaction to announcement by Synairgen that their drug SNG001 has had positive results in initial trials on COVID-19 patients – Science Media Centre AND Trial of Covid-19 drug given via inhaler ‘very promising’, say scientists – The Guardian
Phase 1/2 randomized trial: safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2
21 Jul, 2020 | 09:33h | UTCCommentaries: New study reveals Oxford coronavirus vaccine produces strong immune response – University of Oxford AND Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed – CNN AND Early Oxford-AstraZeneca Coronavirus Vaccine Data ‘Encouraging,’ Scientists Say – NPR
Related Commentary on Twitter
NEW—UK’s #COVID19 vaccine is safe and induces an immune reaction, according to preliminary results https://t.co/rDPlB9fDKr pic.twitter.com/z2t9Aubjim
— The Lancet (@TheLancet) July 20, 2020
Survivorship after COVID-19 ICU stay
21 Jul, 2020 | 09:23h | UTCSurvivorship after COVID-19 ICU stay – Nature Reviews
[Preprint] Covid-19: Six clusters of symptoms could be used as a clinical prediction tool
21 Jul, 2020 | 09:25h | UTCCommentaries: Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool – The BMJ AND Six distinct ‘types’ of COVID-19 identified – King’s College London AND Coronavirus symptoms fall into six different groupings, study finds – The Guardian
Randomized trial: dexamethasone in hospitalized patients with Covid-19
20 Jul, 2020 | 08:18h | UTCCommentary: Trial data support dexamethasone, but not hydroxychloroquine, for COVID-19 – CIDRAP
Related Commentary on Twitter
A randomized controlled trial testing dexamethasone for Covid-19 (the RECOVERY trial) showed that, compared with usual care, this corticosteroid drug reduced 28-day mortality in hospitalized patients. #COVID19 #SARSCoV2
— NEJM (@NEJM) July 18, 2020
The role of chest radiography in confirming Covid-19 pneumonia
20 Jul, 2020 | 08:13h | UTCThe role of chest radiography in confirming covid-19 pneumonia – The BMJ
Related Commentary on Twitter
"No single feature of covid-19 pneumonia on a chest radiograph is specific or diagnostic, but a combination of multifocal peripheral lung changes of ground glass opacity and/or consolidation, which are most commonly bilateral, may be present."#BMJEducation https://t.co/22nRTBVxmj
— The BMJ (@bmj_latest) July 19, 2020
Editorial: research in the context of a pandemic
20 Jul, 2020 | 08:16h | UTCResearch in the Context of a Pandemic – New England Journal of Medicine
Related Commentary on Twitter
"Research in the Context of a Pandemic," an editorial by H. Clifford Lane, MD, and Anthony Fauci, MD, now available. #COVID19 #SARSCoV2
— NEJM (@NEJM) July 18, 2020
Study: household transmission of SARS-CoV-2 is high if the index patient is 10–19 years of age
20 Jul, 2020 | 08:14h | UTCCommentaries: Older Children Spread the Coronavirus Just as Much as Adults, Large Study Finds – The New York Times AND Children over age 10 spread COVID-19 as much as adults, study finds – CTV
Benefits of routine childhood vaccines far outweigh risks of additional COVID-19 transmission in Africa, modeling study suggests
20 Jul, 2020 | 08:07h | UTC
Related Commentary on Twitter
In a new risk-benefit analysis, researchers estimate that for every one excess death due to #COVID19 acquired during routine vaccination clinic visits, 84 deaths in children could be prevented by sustaining routine childhood #immunisation in Africa https://t.co/BBQOwsRMKM
— The Lancet Global Health (@LancetGH) July 18, 2020
Policy responses to the coronavirus pandemic
20 Jul, 2020 | 08:09h | UTCPolicy Responses to the Coronavirus Pandemic – Our World in Data
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
20 Jul, 2020 | 08:06h | UTCRelated: New-Onset Diabetes in Covid-19 – New England Journal of Medicine
Related Commentary on Twitter
#New #COVID19 content: Stefano Del Prato & colleagues review: #COVID-19 in people with #diabetes: understanding the reasons for worse outcomes https://t.co/7eYPmdsgvE pic.twitter.com/y9EmhG8Rsv
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) July 18, 2020
Is coronavirus reinfection possible?
20 Jul, 2020 | 08:01h | UTCIs Coronavirus Reinfection Possible? – Self
Serology testing in the COVID-19 pandemic response
20 Jul, 2020 | 08:02h | UTCSerology testing in the COVID-19 pandemic response – The Lancet Infectious Diseases
Histopathology and ultrastructural findings of fatal COVID-19 infections
20 Jul, 2020 | 08:04h | UTC
Related Commentary on Twitter
NEW Case Series—Histopathology and ultrastructural findings of 14 fatal #COVID19 infections in Washington State shows primary pathology as diffuse alveolar damage, with virus located in the pneumocytes and tracheal epithelium @UWMedicinehttps://t.co/vZggyxhjU1 pic.twitter.com/AFeuiMiH26
— The Lancet (@TheLancet) July 17, 2020
The explosion of new coronavirus tests that could help to end the pandemic
20 Jul, 2020 | 07:57h | UTCThe explosion of new coronavirus tests that could help to end the pandemic – Nature
Why those most at risk of COVID-19 are least likely to respond to a vaccine
20 Jul, 2020 | 07:55h | UTCWhy those most at risk of COVID-19 are least likely to respond to a vaccine – National Geographic
Review: musculoskeletal consequences of COVID-19
20 Jul, 2020 | 07:49h | UTCMusculoskeletal Consequences of COVID-19 – The Journal of Bone & Joint Surgery
Review: clinical presentation and management of COVID ‐19
20 Jul, 2020 | 07:51h | UTCClinical presentation and management of COVID ‐19 – Medical Journal of Australia
How effective does a COVID-19 coronavirus vaccine need to be to stop the pandemic? A new study has answers
17 Jul, 2020 | 08:50h | UTC
Related Commentary on Twitter
How 'good' does a COVID-19 coronavirus vaccine need to be to stop the pandemic? Study: “If only 75% of the population gets vaccinated, the vaccine efficacy would have to be around 70%.” So we still might need a “Plan B” https://t.co/aoHu4L0SYU
— Paul Glasziou (@PaulGlasziou) July 16, 2020
Palliative care for patients with severe Covid-19
17 Jul, 2020 | 08:51h | UTCPalliative care for patients with severe covid-19 – The BMJ
Coronavirus drug and treatment tracker
17 Jul, 2020 | 08:46h | UTCCoronavirus Drug and Treatment Tracker – The New York Times